Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NeuroVista Corp.

www.neurovista.com

Latest From NeuroVista Corp.

Research In Brief

Data preview for Heart Rhythm Society conference in Denver this week. More research news.

Medical Device Clinical Trials

Device Start-Ups Inch Closer To Elusive Epilepsy Treatment

Despite the availability of more than 20 anti-epilepsy drugs, surgery, and a neurostimulation therapy that’s been available for 15 years, a large proportion of the three million patients in the US with epilepsy continue to have seizures. Emerging device companies aim to provide a solution for them.

Medical Device

Deals Update

A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Medical Device

Device Financings: Recent Growth, Future Opportunities

A Reprint--see the article of the same name in In Vivo, May 2008.
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Monitoring Equipment & Devices
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • NeuroBionics Corp.
  • BioNeuronics Corp.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • NeuroVista Corp.
  • Senior Management
  • John F Harris, Pres. & CEO
    W. Douglas Sheffield, PhD, VP, Clin. Res.
  • Contact Info
  • NeuroVista Corp.
    Phone: (206) 267-3700
    100 Fourth Ave. N
    Ste. 600
    Seattle, WA 98109
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register